Sylvester Comprehensive Cancer Center

E-mail a Friend

Funding Opportunities

Sylvester NIH Funding Program

The Sylvester Comprehensive Cancer Center is implementing the Sylvester NIH Funding Program to help support cancer related research. The program will provide supplemental funding to principal investigators who have scored within the fundable range of the NIH Scoring System described below.

Types of Funding Requests

NCI Supplemental Funding

  • NCI R01 Continuation (Type II A0): Applications with a percentile of 30 and lower receive funding of $120,000
  • NCI R01 New (Type I A0): Applications with a percentile of 25 and lower receive funding of $100,000
  • Multiple PI NCI Applications: Will receive up to twice the amount of funding from the Sylvester Comprehensive Cancer Center

NIH Cancer-Related Supplemental Funding

  • NIH R01 Continuation, cancer-related (Type II A0): Applications with a percentile of 25 and lower receive funding of $100,000
  • NIH R01 New, cancer-related (Type II A0): Applications with a percentile of 20 and lower receive $80,000
  • Multiple PI NIH, cancer-related applications/awards: Will receive up to twice the amount of funding from the Sylvester Comprehensive Cancer Center

Eligibility

  • Only Cancer Center members may apply
  • Application must be cancer-related
  • Only 2 projects can be funded within a four year period

For application instructions, guidelines and additional information, please contact:
Ashley Marie Cervera
305-243-4108
amcervera@med.miami.edu

American Cancer Society Institutional Research Grant Projects 2016

The American Cancer Society Institutional Research Grant Pilot Projects Grant provides funds for meritorious cancer research that cannot be readily supported through other funding mechanisms. The primary purpose of the ACS IRG is to provide seed funds for the initiation of promising new projects or novel ideas by junior faculty members that do not have external grant support.

Eligibility: Applicants should have less than six years of experience in an independent research position or faculty appointment and must not currently hold any peer-reviewed funding. Senior faculty and postdoctoral fellows are not eligible to apply.

Application Deadline: April 4, 2016

Congratulations to the 2015 awardees:

  • Alberto J. Caban – Martinez, DO, Ph.D., MPH, CPH, Associate Professor (Rank Pending), “Determining Occupational Uncertainty in Sources and Exposures (DOUSE) Firefighter Gear Pilot Study”
  • Breelyn A. Wilky, M.D., Assistant Professor, “Profiling Tumor-Infiltrating and Circulating Lymphocytes in Sarcoma Patients Treated With Alternating Axitinib, a Pan-VEGF Inhibitor, and Pembrolizumab, an Anti-PD1 Monoclonal Antibody”
  • Michael, VanSaun, Ph.D., Research Assistant Professor, “Modulating Adiponectin Receptors in Pancreatic Cancer”

For application, guidelines and additional information, please contact:
Ashley Marie Cervera
305-243-4108
amcervera@med.miami.edu

Sylvester Clinical Trial Acceleration Grants 2016

The goal of this program is to support the development of highly innovative, programmatically important, investigator initiated, cooperative group or industry sponsored therapeutic trials. While investigator initiated trials continue to be a high priority, and historically have been underfunded, other types of trials may also test concepts of high value to the programs of the Cancer Center and to the community of cancer patients. In order to rapidly accrue to our cancer clinical trials, funds will be provided to accelerate trials that are highly competitive. Proposals will be assessed three times a year.

Budget & Project Period: Each award will be for up to $100,000 and will cover clinical trial costs such as patient care fees, correlative/translational study fees, advertising/marketing fees, etc. The grant period is for one year.
Eligibility: Only Cancer Center faculty members may apply. The protocol must be a therapeutic trial, but may focus on any type of cancer/s. PRC approval is required for any consideration.

Congratulations to the 2015 Cycle 2 awardee:

  • Breelyn A. Wilky, M.D., Assistant Professor of Sarcoma Program for, “A Phase II Trial of Concurrent Axitinib and Pembrolizumab in Subjects with Advanced Alveolar Soft Part Sarcoma (ASPS) and Other Soft Tissue Sarcomas (STS)”

Special thanks to all the applicants and reviewers that participated during the award process.

Congratulations to the 2015 Cycle 3 awardee:

  • Marc E. Lippman, M.D.MACP FRCP , Leonard M. Miller Professor of Internal Medicine, Psychiatry and Behavioral Sciences Deputy Director, Sylvester Comprehensive Cancer Center, “Mechanisms by Which Successful Treatment of Major Depression in Breast Cancer Patients Reduces Disease Progression and Mortality”

Application Deadlines: April 15, 2016, August 12, 2016 & February 10, 2017

For application, guidelines and additional information, please contact:
Ashley Marie Cervera
305-243-4108
amcervera@med.miami.edu

Sylvester Equipment Grant Program

The objective of the program is to (a) assist individual investigators with the purchase of equipment that will be made available to other cancer center members on an as needed basis; (b) to assist investigators in purchasing expensive research instruments that can only be justified on a shared – use basis. This program will fund a group of investigators to purchase a single specialized and commercially available instrumentation or integrated system that costs a maximum of $100,000. The funds for this program may be used towards the cost of more expensive instruments, as long as the investigator, group of investigators, identifies another funding source for the difference.

Congratulations to the 2015 awardees:

  • William J. Harbour, M.D., Professor and Vice Chairman, Department of Ophthalmology, “Inverted Cell Culture Microscope”
  • Kerry L. Burnstein, Ph.D.; Professor Department of Mollecular & Cellular Pharmacology, “Microscope for Live Cell Imaging (IncuCyte Zoom)”

Thanks to all the applicants and reviewers that participated.

Sylvester Tissue Bank Support Grants 2015

The UM Sylvester Comprehensive Cancer Center’s Tissue Bank Core Facility (TBCF) supports translational cancer research by center members by banking tissues to be used for research by Sylvester Comprehensive Cancer Center (SCCC) members. The present new grant mechanism will permit the use of up to eighty samples or the equivalent of $20,000 worth of banked human tumor specimens for pilot research projects. This grant aims to allow PIs to obtain preliminary data to support subsequent extramural grant applications. It is our long term goal to increase the number of extramurally funded projects that use banked specimens.

All applicants must use TBCF services with standardized operating procedures for consenting, protection and privacy of patient data, specimen procurement and processing, quality control, secured specimen storage, retrieval, distribution and provision of relevant de-identified clinical data. To date the TBCF has procured over 2,000 banked tissue/blood samples from various cancers and our goal is to make these available for meritorious research.

Congratulations to the 2015 Cycle 2 awardee:

  • Michael Samuels, M.D., Associate Professor of Clinical, Radiation Oncology , ““Evaluation of Harvested Oropharyngeal Tissue for Human Papillomavirus Episomal DNA and Infectious Virion Production””

Congratulations to the 2015 Cycle 3 awardee:

  • Justin M. Watts, MD , Assistant Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, ““Characterization of Primary Patient Material for Therapeutic Gain: The Leukemia Tissue Repository”

Special thanks to all the applicants and reviewers that participated during the award process.

Sylvester/Jay Weiss Institute for Health Equity Pilot Grants

The Jay Weiss Institute for Health Equity at the Sylvester Comprehensive Cancer Center is pleased to announce one year pilot projects in the amount of up to $75,000 each. These projects should focus on identifying and/or reducing disparities in cancer outcomes. The goal of this funding mechanism is to promote interdisciplinary dialogue about cancer disparities and enable collaboration that can lead to future research and intervention. These applications will be evaluated primarily on potential for NCI R01 application. We encourage applications from persons with expertise in clinical oncology research, basic molecular mechanistic approaches, translational science, population genetics, epidemiology, bio-behavioral oncology, and community-based participatory research (CBPR). One of the major goals for this year is to promote collaboration between at least two cancer center members from different programs of research.

Sylvester Comprehensive Cancer Bridge Funding Program

The Sylvester Comprehensive Cancer Center is pleased to announce the support of bridge funding grants. These awards are intended to assist faculty in maintaining their research program in the event of a funding lapse during the process of applying for additional extramural funding.

Congratulations to the 2015 awardees:

  • Ramiro E. Verdun, Ph.D., Role of Telomeric Proteins in Antibody Class Switch Recombination”
  • Olveen Carrasquillo, M.D., MPH Erin Kobetz, Ph.D., MPH , “South Florida Center of Cancer Disparities”
  • Priyamvada Rai, Ph.D. , “Targeting Early Adaptations in Androgen – Refractory Prostate Cancer”
  • Feng Gong, Ph.D. ,“The Role of Chromatin Remodeling Complexes in DNA Repair”

Funding Newsletter

The monthly Funding Newsletter compiles information on local and national awards/grants for doctors and researchers. Included are NIH notices, foundation and other sources, program announcements, and requests for applications.

Download the February 2016 Funding Newsletter

E-mail a Friend